IHC for PD-L1 has been performed on paraffin-embedded tumor samples from core needle biopsies from 94 breast cancer patients before NAC, identifying PD-L1 expression as a predictor of pCR and a prognostic factor of disease-free survival (DFS) in breast cancer patients (27). This evidence concerns the gene CD274 and neoplasm.